111 Common Stock Net 2018-2025 | YI

111 common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.
111 Annual Common Stock Net
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
111 Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-09-30 $0
2017-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.063B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.412B 59.05
Tempus AI (TEM) United States $12.731B 0.00
Doximity (DOCS) United States $12.055B 53.63
Hims & Hers Health (HIMS) United States $9.805B 80.33
IRhythm Technologies (IRTC) United States $5.243B 0.00
Hinge Health (HNGE) United States $4.466B 0.00
Inspire Medical Systems (INSP) United States $2.752B 40.46
Privia Health (PRVA) United States $2.596B 192.27
Heartflow (HTFL) $2.379B 0.00
Enovis (ENOV) United States $1.715B 9.06
10x Genomics (TXG) United States $1.663B 0.00
Phreesia (PHR) United States $1.648B 0.00
Omnicell (OMCL) United States $1.458B 28.10
Schrodinger (SDGR) United States $1.425B 0.00
Clover Health Investments (CLOV) United States $1.302B 0.00
Claritev (CTEV) United States $1.088B 0.00
Evolent Health (EVH) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.654B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.470B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.355B 0.00
Carlsmed (CARL) United States $0.320B 0.00
TruBridge (TBRG) United States $0.291B 51.03
SOPHiA GENETICS SA (SOPH) Switzerland $0.242B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.139B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.133B 0.00
CareCloud (CCLD) United States $0.112B 5.08
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Precipio (PRPO) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00